Patient Input Mandated to Improve Medicare Drug Plan Transparency and Access.
This law requires the government to hold public listening sessions where patients and caregivers can directly suggest improvements to Medicare Part D prescription drug plans. The goal is to enhance plan transparency, simplify the selection process, and make it easier to navigate complex requirements like prior authorization. Recommendations gathered will be used to review and potentially change existing regulations.
Key points
The government must convene public, patient-focused sessions by the end of 2024 to gather feedback on Medicare Part D drug coverage.
Discussions will focus on making drug plan information clearer, improving tools for plan selection, and simplifying access rules (like step therapy).
The feedback collected will directly inform potential regulatory changes aimed at improving beneficiaries' access to necessary medications.
Expired
Citizen Poll